Citation Impact
Citing Papers
HLA-DQ gene polymorphism in primary IgA nephropathy in three European populations
1996
Risk‐adjusted relationship between voriconazole utilization and non‐melanoma skin cancer among lung and heart/lung transplant patients
2013
In situ click chemistry generation of cyclooxygenase-2 inhibitors
2017 Standout
Enalapril treatment of posttransplant erythrocytosis: efficacy independent of circulating erythropoietin levels
1995
Posttransplantation Anemia at 12 Months in Kidney Recipients Treated with Mycophenolate Mofetil
2006
Post Transplant Erythrocytosis in Hypercalcemic Renal Transplant Recipients
2003
Bone Marrow–Derived Cells Do Not Contribute Significantly to Collagen I Synthesis in a Murine Model of Renal Fibrosis
2006 StandoutNobel
A randomized prospective study comparing low-dose OKT3 to low-dose ATG for the treatment of acute steroid-resistant rejection episodes in kidney transplant recipients
1998
Siglecs and their roles in the immune system
2007 Standout
Pathophysiology of Progressive Nephropathies
1998 Standout
Comparison of Methods for Determining Renal Function Decline in Early Autosomal Dominant Polycystic Kidney Disease
2006
Predictive Capacity of Pre-Donation GFR and Renal Reserve Capacity for Donor Renal Function After Living Kidney Donation
2006
Sjögren's syndrome
2005 Standout
RENAL DISEASE ASSOCIATED WITH HEPATITIS C INFECTION AFTER KIDNEY AND LIVER TRANSPLANTATION1
2000
A Predictive Model for Progression of Chronic Kidney Disease to Kidney Failure
2011 Standout
The genetics of IgA nephropathy
2007
Fluorophore‐Labeled Cyclooxygenase‐2 Inhibitors for the Imaging of Cyclooxygenase‐2 Overexpression in Cancer: Synthesis and Biological Studies
2013
Effect of Gender on the Progression of Nondiabetic Renal Disease
2000
Understanding Fc Receptor Involvement in Inflammatory Diseases: From Mechanisms to New Therapeutic Tools
2019
Human schistosomiasis
2006 Standout
Evaluation of the Modification of Diet in Renal Disease Study Equation in a Large Diverse Population
2007
Chronic kidney disease: the global challenge
2005
HLA Has Strongest Association with IgA Nephropathy in Genome-Wide Analysis
2010 StandoutNobel
Hepatitis C infection and the patient with end-stage renal disease
2002
Genetic Studies of IgA Nephropathy
2005
Renal-Artery Stenosis
2001 Standout
Performance of Different Prediction Equations for Estimating Renal Function in Kidney Transplantation
2004
Performance of the Cockcroft-Gault and Modification of Diet in Renal Disease Equations in Estimating GFR in Ill Hospitalized Patients
2005
Increased Erythropoiesis in Mice Injected With Submicrogram Quantities of Pseudouridine-containing mRNA Encoding Erythropoietin
2012 StandoutNobel
A Trial of Darbepoetin Alfa in Type 2 Diabetes and Chronic Kidney Disease
2009 Standout
Global Prevalence of Chronic Kidney Disease – A Systematic Review and Meta-Analysis
2016 Standout
Intrarenal expression of microRNAs in patients with IgA nephropathy
2009
Factors influencing serum cystatin C levels other than renal function and the impact on renal function measurement
2004
Molecular and Serologic Analysis of Hla Genes and Immunoglobulin Allotypes in Iga Nephropathy
1994
Kidney function estimating equations: where do we stand?
2006
Role of the deletion of polymorphism of the angiotensin converting enzyme gene in the progression and therapeutic responsiveness of IgA nephropathy.
1995
Transplantation versus haemodialysis in elderly patients
1997
The DQw7 allele at the HLA-DQB locus is associated with susceptibility to IgA nephropathy in Caucasians
1991
Diagnosis, management, and treatment of hepatitis C: An update # † ‡
2008 Standout
Malignancy in Renal Transplantation
2004
Chronic kidney disease
2011 Standout
Assessing Kidney Function — Measured and Estimated Glomerular Filtration Rate
2006 Standout
A New Equation to Estimate Glomerular Filtration Rate
2009 Standout
THE IMPACT OF BODY MASS INDEX ON RENAL TRANSPLANT OUTCOMES
2002
MDRD Equations for Estimation of GFR in Renal Transplant Recipients
2005
Chronic Renal Failure after Transplantation of a Nonrenal Organ
2003 Standout
Blockade of Calcium Influx through L-Type Calcium Channels Attenuates Mitochondrial Injury and Apoptosis in Hypoxic Renal Tubular Cells
2004
Acute kidney injury
2019 Standout
Is the loss of health‐related quality of life during renal replacement therapy lower in elderly patients than in younger patients?
2001
The risk of recurrence of hemolytic uremic syndrome after renal transplantation in children
2003
The etiology of glomerulonephritis: roles of infection and autoimmunity
2014
Incidence of recombinant erythropoietin (EPO) hyporesponse, EPO-associated antibodies, and pure red cell aplasia in dialysis patients
2005
Posttransplant Erythrocytosis: An Enigma Revisited
1994
Efficacy and tolerance of interferon-α2b in the treatment of chronic hepatitis C virus infection in haemodialysis patients. Pre- and post-renal transplantation assessment
1999
Performance of Creatinine-Based Estimates of GFR in Kidney Transplant Recipients: A Systematic Review
2008
The changing face of schistosomal glomerulopathy
2004
Worldwide access to treatment for end-stage kidney disease: a systematic review
2015 Standout
Geographic Variation in End-Stage Renal Disease Incidence and Access to Deceased Donor Kidney Transplantation
2010
Measuring GFR: A Systematic Review
2014
Serological and genetic factors in early recurrence of IgA nephropathy after renal transplantation
2007
Hepatitis C and renal disease: an update
2003
Mitochondrial Membrane Permeabilization in Cell Death
2007 Standout
Advanced glycation end products and vascular inflammation: implications for accelerated atherosclerosis in diabetes
2004
Costimulation Blockade with Belatacept in Renal Transplantation
2005 Standout
Demography of paediatric renal care in Europe: organization and delivery
2004
A COMPARISON OF THE EFFECTS OF DIALYSIS AND RENAL TRANSPLANTATION ON THE SURVIVAL OF OLDER UREMIC PATIENTS
2000
Histologic subclassification of IgA nephropathy: A clinicopathologic study of 244 cases
1997
IgA nephropathy
1995
An Alternative Formula to the Cockcroft-Gault and the Modification of Diet in Renal Diseases Formulas in Predicting GFR in Individuals with Type 1 Diabetes
2005
Body-mass index and cause-specific mortality in 900 000 adults: collaborative analyses of 57 prospective studies
2009 Standout
Revised Equations for Estimated GFR From Serum Creatinine in Japan
2009 Standout
Influence of Clinical and Histological Features on Actuarial Renal Survival in Adult Patients With Idiopathic IgA Nephropathy, Membranous Nephropathy, and Membranoproliferative Glomerulonephritis: Survey of the Recent Literature
1992
Tolvaptan in Patients with Autosomal Dominant Polycystic Kidney Disease
2012 Standout
Histological differences in new-onset IgA nephropathy between children and adults
2006
Immune cell dysfunction and inflammation in end-stage renal disease
2013
Prevalence of Chronic Kidney Disease in the United States
2007 Standout
Cytochrome P450 enzymes in drug metabolism: Regulation of gene expression, enzyme activities, and impact of genetic variation
2013 Standout
Simultaneous Reconstruction of Infrarenal Abdominal Aorta and Renal Arteries
1992
Immunosuppressive Drugs for Kidney Transplantation
2004 Standout
The impact of gender on the progression of chronic renal disease
1995
Association between obesity and kidney disease: A systematic review and meta-analysis
2007
Sirolimus for Kaposi's Sarcoma in Renal-Transplant Recipients
2005 Standout
Chronic Kidney Disease
2016 Standout
Anaemia in haemodialysis patients of five European countries: association with morbidity and mortality in the Dialysis Outcomes and Practice Patterns Study (DOPPS)
2003
Early treatment with corticosteroids ameliorates proteinuria, proliferative lesions, and mesangial phenotypic modulation in adult diffuse proliferative IgA nephropathy
2000 StandoutNobel
Systematic Review: Kidney Transplantation Compared With Dialysis in Clinically Relevant Outcomes
2011 Standout
Long-term cyclophosphamide treatment for recurrent type I membranoproliferative glomerulonephritis after transplantation
2000
Predicting initiation and progression of chronic kidney disease: Developing renal risk scores
2006
Anemia of Chronic Disease
2005 Standout
Lack of angiotensin II–facilitated erythropoiesis causes anemia in angiotensin-converting enzyme–deficient mice
2000 StandoutNobel
Primary Sjögren's Syndrome with Central Nervous System Disease Mimicking Multiple Sclerosis
1986
Cell Biology of the Glomerular Podocyte
2003 Standout
Predictive Performance of Renal Function Equations in Renal Transplant Recipients: An Analysis of Patient Factors in Bias
2005
Transparent Reporting of a multivariable prediction model for Individual Prognosis Or Diagnosis (TRIPOD): Explanation and Elaboration
2015 Standout
Advanced Glycation End Products
2006 Standout
In Vivo mRNA CAR T Cell Engineering via Targeted Ionizable Lipid Nanoparticles with Extrahepatic Tropism
2023 StandoutNobel
Infections in solid-organ transplant recipients
1997
Sex and Gender Differences in Risk, Pathophysiology and Complications of Type 2 Diabetes Mellitus
2016 Standout
Special Issue: KDIGO Clinical Practice Guideline for the Care of Kidney Transplant Recipients
2009 Standout
Incidences, Treatments, Outcomes, and Sex Effect on Survival in Patients With End-Stage Renal Disease by Diabetes Status in Australia and New Zealand (1991–2005)
2007
Target of rapamycin inhibitors (TOR-I; sirolimus and everolimus) for primary immunosuppression in kidney transplant recipients
2006
Intensive Diabetes Treatment and Cardiovascular Disease in Patients with Type 1 Diabetes
2005 Standout
Using Standardized Serum Creatinine Values in the Modification of Diet in Renal Disease Study Equation for Estimating Glomerular Filtration Rate
2006 Standout
The diagnosis and management of nonalcoholic fatty liver disease: Practice guidance from the American Association for the Study of Liver Diseases
2017 Standout
The epidemiology of adult chronic kidney disease in a population-based study in Iran: prevalence and associated risk factors.
2009
Practice Guidelines for the Diagnosis and Management of Aspergillosis: 2016 Update by the Infectious Diseases Society of America
2016 Standout
Cardiac Disease Evaluation and Management Among Kidney and Liver Transplantation Candidates
2012
Aspergillus fumigatusand Aspergillosis
1999 Standout
Risk Prediction Models for Patients With Chronic Kidney Disease
2013
Mechanisms of Diabetic Complications
2013 Standout
Reactive Oxygen Species (ROS)-Based Nanomedicine
2019 Standout
Cytochrome P4503APolymorphisms and Immunosuppressive Drugs: An Update
2007
Progression, remission, regression of chronic renal diseases
2001
Chronic Renal Diseases: Renoprotective Benefits of Renin–Angiotensin System Inhibition
2002
Long‐Term Outcome After Coronary Angioplasty in Renal Transplant and Hemodialysis Patients
2005
Is alanine aminotransferase a good marker of histologic hepatic damage in renal transplant patients with hepatitis C virus infection?
2005
Clinical practice guidelines for managing dyslipidemias in kidney transplant patients: a report from the Managing Dyslipidemias in Chronic Kidney Disease Work Group of the National Kidney Foundation Kidney Disease Outcomes Quality Initiative
2004
Losartan, an angiotensin II type 1 receptor antagonist, lowers hematocrit in posttransplant erythrocytosis.
1998
Pharmacogenomics: Translating Functional Genomics into Rational Therapeutics
1999 StandoutScience
Estimating kidney function in adults using formulae
2005
Association of estimated glomerular filtration rate and albuminuria with all-cause and cardiovascular mortality in general population cohorts: a collaborative meta-analysis
2010 Standout
National Kidney Foundation Practice Guidelines for Chronic Kidney Disease: Evaluation, Classification, and Stratification
2003 Standout
Works of F. Berthoux being referenced
Natural History of Primary IgA Nephropathy
2008
Thymoglobulin Induction and Sirolimus Versus Tacrolimus in Kidney Transplant Recipients Receiving Mycophenolate Mofetil and Steroids
2010
Prognostic Factors in Mesangial IgA Glomerulonephritis: An Extensive Study With Univariate and Multivariate Analyses
1991
Hepatitis C Virus Infection and Disease in Renal Transplantation
1995
Advantage of antithymocyte globulin induction in sensitized kidney recipients: a randomized prospective study comparing induction with and without antithymocyte globulin
1998
Interleukin-10 Promoter Polymorphisms and Susceptibility to Skin Squamous Cell Carcinoma After Renal Transplantation
2003
Atteintes rénales graves au cours d’un traitement par anti-inflammatoires non stéroïdiens arylcarboxyliques : bilan d’une enquête nationale de pharmacovigilance
2006
Predicting Glomerular Filtration Rate in Kidney Transplantation: Are the K/DOQI Guidelines Applicable?
2005
G protein β3 subunit C825T polymorphism in primary IgA nephropathy
2004
Antithymocyte Globulin (ATG) Induction Therapy and Disease Recurrence in Renal Transplant Recipients With Primary IgA Nephropathy
2008
Epidemiological data of treated end-stage renal failure in the European Union (EU) during the year 1995: report of the European Renal Association Registry and the National Registries
1999
Single nucleotidic polymorphism 844 A->G of FCAR is not associated with IgA nephropathy in Caucasians
2011
Polymorphisms of the tumour necrosis factor gene at position -308 and TNFd microsatellite in primary IgA nephropathy
2003
IL5RA and TNFRSF6B Gene Variants Are Associated With Sporadic IgA Nephropathy
2008
Different glycosylation profile of serum IgA1 in IgA nephropathy according to the glomerular basement membrane thickness: Normal versus thin
2003
Autoantibodies Targeting Galactose-Deficient IgA1 Associate with Progression of IgA Nephropathy
2012
Systematic evaluation of liver disease in hepatitis C virus-infected renal transplant recipients: clinical and pathological study
2000
HCV liver disease in renal transplantation: a clinical and histological study
1996
A multicentre study of registration on renal transplantation waiting list of the elderly and patients with type 2 diabetes
2003
Glomerular disease during HCV infection in renal transplantation
1996
Significant Risk Factors for Occurrence of Cancer After Renal Transplantation: A Single Center Cohort Study of 1265 Cases
2009
Excessive body weight as a new independent risk factor for clinical and pathological progression in primary IgA nephritis
2001
Predicting the Risk for Dialysis or Death in IgA Nephropathy
2011
Assessing renal graft function in clinical trials: Can tests predicting glomerular filtration rate substitute for a reference method?
2003
Efficacy and safety of de novo or early everolimus with low cyclosporine in deceased-donor kidney transplant recipients at specified risk of delayed graft function: 12-month results of a randomized, multicenter trial
2010
CC-chemokine receptor five gene polymorphism in primary IgA nephropathy: The 32 bp deletion allele is associated with late progression to end-stage renal failure with dialysis
2006
Ganciclovir Therapy of Symptomatic Cytomegalovirus Infection in Renal Transplant Recipients
1989
Results of a 1-year randomized controlled trial with omega-3 fatty acid fish oil in renal transplantation under triple immunosuppressive therapy.
1995
The child-adult interface
1996
[Influence of dialysis and kidney transplantation on the survival of patients with end-stage chronic kidney failure. A multifactorial analysis].
1991
Gm , Am , Pi and Km MARKERS IN MESANGIAL IGA GLOMERULONEPHRITIS
1981
Prevalence of IgA2 Deposits in IgA Nephropathies
1980
Randomized prospective study comparing OKT3 and antithymocyte globulins for treatment of the first acute cellular rejection of kidney allografts.
1994
Genetic investigation in mesangial IgA nephropathy
1982
European Best Practice Guidelines for Renal Transplantation (Part 2).
2002
[Severe renal adverse events with arylcarboxylic non-steroidal anti-inflammatory drugs: results of a eight-year French national survey].
2006
Transplantation Report 2: Pre-emptive renal transplantation in adults aged over 15 years
1996
Epidemiology and demography of treated end-stage renal failure in the elderly: from the European Renal Association (ERA-EDTA) registry
1998
New insights and treatment in posttransplant polycythemia (erythrocytosis) of renal recipients.
1993
Transplantation Report 1: renal transplantation in recipients aged 60 years or older at time of grafting
1996
Incidence of Delayed Graft Function and Wound Healing Complications After Deceased-Donor Kidney Transplantation Is not Affected by De Novo Everolimus
2009
Tackling inactivity on the waiting list for transplantation
2009
Renal transplantation in mesangioproliferative glomerulonephritis (MPGN): relationship between the high frquency of recurrent glomerulonephritis and hypocomplementemia.
1975
End stage renal disease and dialysis report
1996
Comparison of pathological lesions on repeated renal biopsies in 73 patients with primary IgA glomerulonephritis: value of quantitative scoring and approach to final prognosis.
1990
Long-term Kinetic of T-lymphocyte Subsets in Kidney-Transplant Recipients: Influence of Anti–T-cell Antibodies and Association with Posttransplant Malignancies
2005
MULTIPLE SCLEROSIS WITH HYPOCOMPLEMENTÆMIA
1975
[Comparative evaluation of the function of each kidney using Tc 99m DTPA].
1984